CurveBeam AI Adds Medical-Device Veteran To Board, Grants 4 Million Share Rights
CurveBeam AI appointed Dan Pryor as a non-executive director and Audit & Risk Committee chair, citing his experience in medical devices, strategic transactions and governance as the company pursues broader commercial adoption. Pryor received 4 million share rights vesting over three years and holds 1.25 million ordinary shares; the company also disclosed annual share-right grants valued at approximately US$130,000, subject to shareholder approval.
Closing price · 2026-10-26: $0.020 · -4.76%